Format

Send to

Choose Destination
See comment in PubMed Commons below
Birth Defects Res C Embryo Today. 2013 Jun;99(2):134-46. doi: 10.1002/bdrc.21035.

Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects.

Author information

1
Department of Health and Human Services, Division of the NTP, National Institute of Environmental Health Sciences, National Toxicology Program (NTP) Laboratories Branch, National Institutes of Health, Research Triangle Park, NC, USA.

Abstract

Diethylstilbestrol (DES) is a potent estrogen mimic that was predominantly used from the 1940s to the 1970s by pregnant women in hopes of preventing miscarriage. Decades later, DES is known to enhance breast cancer risk in exposed women and cause a variety of birth-related adverse outcomes in their daughters such as spontaneous abortion, second trimester pregnancy loss, preterm delivery, stillbirth, and neonatal death. Additionally, children exposed to DES in utero suffer from sub/infertility and cancer of reproductive tissues. DES is a pinnacle compound that demonstrates the fetal basis of adult disease. The mechanisms of cancer and endocrine disruption induced by DES are not fully understood. Future studies should focus on common target tissue pathways affected and the health of the DES grandchildren.

KEYWORDS:

DES; breast; cancer; development; diethylstilbestrol; fetal basis of adult disease; pregnancy

PMID:
23897597
PMCID:
PMC3817964
DOI:
10.1002/bdrc.21035
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center